[Effect of a purified glycoprotein substance extracted from Klebsiella pneumoniae in the clinical course of acute infections of the airways in patients with chronic bronchitis. Italian Group for the Study of Biological Immunomodulators].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001426:Bacterial Proteins / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011897:Random Allocation
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; C037567:glycoprotein, Klebsiella pneumoniae
Effetto di un composto glicoproteico purificato estratto da Klebsiella pneumoniae sul decorso clinico di infezioni acute delle vie aeree in pazienti affetti da bronchite cronica. Gruppo Italiano per lo Studio degli Immunomodulanti Biologici.